Elizabeth M. McNally|Mitchell S.V. Elkind|Ivor J. Benjamin|Mina K. Chung|Glenn H. Dillon|Adrian F. Hernandez|Chinwe Ibeh|Donald M Lloyd-Jones|Louise D. McCullough|Loren E. Wold|Davene R. Wright|Joseph C. Wu
Impact of the COVID-19 Pandemic on Cardiovascular Science: Anticipating Problems and Potential Solutions: A Presidential Advisory From the American Heart Association
coronavirus disease 2019 covid19 pandemic worldwide repercussions health care research spring 2020 noncovid19 research halted hindering research across spectrum laboratorybased experimental science clinical research second half 2020 first half 2021 biomedical research including cardiovascular science gradually restarted many restrictions onsite activities limited clinical research participation challenges associated working home caregiver responsibilities compounding impediments much global biomedical research infrastructure redirected toward vaccine testing deployment redirection supply chains personnel equipment additionally hampered restoration normal research activity transition virtual interactions offset limitations adequately replace need scientific exchange collaboration outline key steps reinvigorate biomedical research including call increased support national institutes health also call academic institutions publishers reviewers supervisors consider impact covid19 assessing productivity recognizing pandemic affect equally identify trainees junior investigators especially caregiving roles risk lost biomedical workforce identify steps reduce loss key investigators although global pandemic highlighted power biomedical science define treat protect threats human health significant investment biomedical workforce required maintain promote wellbeing